Your browser doesn't support javascript.
loading
Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000.
Kantarjian, Hagop M; DiNardo, Courtney D; Nogueras-Gonzalez, Graciela M; Kadia, Tapan M; Jabbour, Elias; Bueso-Ramos, Carlos E; O'Brien, Susan M; Konopleva, Marina; Jain, Nitin B; Daver, Naval G; Shpall, Elizabeth J; Champlin, Richard E; Simkins, Aron; Garcia-Manero, Guillermo; Keating, Michael J; Huang, Xuelin; Cortes, Jorge E; Pierce, Sherry A; Ravandi, Farhad; Freireich, Emil J.
Afiliação
  • Kantarjian HM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Nogueras-Gonzalez GM; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Bueso-Ramos CE; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • O'Brien SM; Chao Family Comprehensive Cancer Center, University of California at Irvine, Irvine, California.
  • Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jain NB; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Daver NG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shpall EJ; Department of Cellular Therapy and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Champlin RE; Department of Cellular Therapy and Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Simkins A; Department of Internal Medicine, University of Texas Health Science Center, Houston, Texas.
  • Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Keating MJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Cortes JE; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pierce SA; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Freireich EJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Cancer ; 124(12): 2534-2540, 2018 06 15.
Article em En | MEDLINE | ID: mdl-29645075
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Indução de Remissão / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Indução de Remissão / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia de Salvação / Recidiva Local de Neoplasia Tipo de estudo: Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article